Clinical Trial Update: Tesamorelin Effects on Liver Fat and Histology in HIV [NA]

View source ↗

Summary

Clinical trial update reporting on tesamorelin effects on liver fat and histology in HIV patients with NAFLD/NASH; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Tesamorelin (tesamorelin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Human Immunodeficiency Virus (HIV), Nonalcoholic Fatty Liver Disease (NAFLD) | NA | Status: COMPLETED | Results posted: 2020-01-13